Product information

Current status:

Cancelled Post Market

Current status date:

1997-01-30

Original market date: ^{See footnote 1}

1984-12-31

Product name:

SELEPEN INJ 40MCG/ML USP

DIN:

01945335 Electronic product monograph is not available

Company:

LYPHOMED, DIVISION OF FUJISAWA CANADA INC.
800 625 Cochrane Drive
Markham
Ontario
Canada L3R 9R9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

40:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS

Active ingredient group (AIG) number:^{See footnote5}

0106697007